Webinar - COVID-19 Opportunities and Investment Support Measures for Medical Industry in Thailand -

Thailand Board of Investment (BOI), European office cordially invites medical companies to join our webinar on June 4 @ 11:00 hr with the BOI headquarters and Food and Drug Administration (FDA) in Bangkok for the latest updates on BOI support measures, laws and regulations on doing business in the Thai medical sector during COVID-19 crisis.

Webinar speakers will share their insights on:

• Current situation, perspectives from the local & international business communities in Thailand

• Support measures & mitigating measures on COVID-19 outbreak

• Introduction to Thailand Food and Drug Administration

• Basic requirements for health products registrations

• Experience of European companies in doing business in Thailand 


Agenda (CET)

11:00 Current situation and support measures for the medical industry in Thailand. Ms Duangjai Asawachintachit, Secretary General, Thailand Board of Investments 

11:15 Laws and regulation on doing business for the medical sector in Thailand, Ms Worasuda Yoongthong, Acting Director Division of Innovative Health Products and Services, Thai Food and Drug Administration, Ministry of Public Health 

11:30 Case study - Experience of doing business in the medical sector in Thailand, Dr Armin Wiesler, Head of Animal Health South East Asia South Korea, General Manager Thailand, Boehringer Ingelheim 

11:40 Case study - Experience of doing business in the medical sector in Thailand, Mr Paul Santing, Director Global Business Development, Steris Ast 

11:50 Q&A 12:00 End of webinar session